Answer
Brivaracetam's anticonvulsant action is believed to arise primarily from high-affinity, selective binding to synaptic vesicle protein 2A (SV2A), which modulates neurotransmitter exocytosis, although the protein's exact role remains unclear.
Sources for this answer
- Briviact 10 mg film-coated tabletsUCB Pharma Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 18Document updated
Sources checked